Hercules Capital, Inc. (HCXY)

Kroll Bond Rating Agency recently reaffirmed Hercules Capital, Inc.'s investment-grade BBB+ rating, citing its diversified portfolio, strong operating history, and robust risk management. This affirmation supports Hercules Capital's access to funding and its strategy as a specialist lender to technology and life sciences companies. Despite positive Q2 2026 earnings and future revenue projections, investors are advised to consider potential risks related to sector concentration and competitive pressures on loan pricing.

Bragar Eagel & Squire, P.C., a shareholder rights law firm, is investigating potential claims against Hercules Capital, Inc. (NYSE:HTGC) on behalf of long-term stockholders. This investigation follows a class action complaint filed on March 20, 2026, alleging that Hercules made false or misleading statements regarding its due diligence in deal sourcing, loan origination, and portfolio valuation processes. The firm encourages investors who suffered losses during the Class Period (May 1, 2025, and February 27, 2026) to contact them.

Kroll Bond Rating Agency recently reaffirmed Hercules Capital, Inc.'s BBB+ investment grade rating, highlighting its diversified portfolio, strong operating history, and sound risk management. This rating supports Hercules Capital's ability to access funding, which is crucial for its growth, despite ongoing sector concentration risks and competitive pressures. The company also reported strong Q2 2026 earnings, reinforcing its financial health and investment appeal.

Hercules Capital, Inc. (NYSE: HTGC) announced that Kroll Bond Rating Agency, Inc. (KBRA) has affirmed its investment grade corporate and credit rating of BBB+, with a stable outlook. This affirmation recognizes Hercules Capital's diversified investment portfolio, strong operating history, appropriate leverage, robust risk management, and proven access to capital markets. The company specializes in providing senior secured venture growth loans to high-growth, venture capital-backed technology and life sciences companies.

Hercules Capital, Inc. has received an affirmed investment grade corporate and credit rating of BBB+ from Kroll Bond Rating Agency, Inc. (KBRA). This rating reflects the company's diversified investment portfolio, strong operating history spanning over 23 years, and appropriate leverage metrics. KBRA highlighted Hercules Capital's robust risk management, experienced investment team, and proven access to capital markets as key factors supporting the favorable rating and stable outlook.